RK Capital Management (Colorado)’s Trinity Biotech TRIB Stock Holding History

RK Capital Management (Colorado)’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-113,094	Closed	-$6.47M	–	56
2015 Q3	$6.47M	Sell	113,094 -7,240	-6%	-$583K	1.18%	41
2015 Q2	$10.9M	Hold	120,334	–	–	1.97%	24
2015 Q1	$11.6M	Buy	120,334 +40,845	+51%	+$3.78M	2.31%	20
2014 Q4	$6.96M	Buy	79,489 +4,480	+6%	+$386K	1.38%	37
2014 Q3	$6.85M	Buy	75,009 +10,353	+16%	+$1.12M	1.4%	37
2014 Q2	$7.45M	Buy	64,656 +7,460	+13%	+$884K	1.48%	36
2014 Q1	$6.93M	Buy	+57,196	New	+$7.5M	1.4%	35

Other funds holding TRIB

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

AAM

ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

LAM

Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

RK Capital Management (Colorado)'s TRIB Position: Q4 2015 in Review

RK Capital Management (Colorado) sold out of Trinity Biotech (TRIB) in Q4 2015, closing a stake of 113,094 shares — an estimated $6.47M sold.

RK Capital Management (Colorado) first reported a position in TRIB in Q1 2014 and held it in 7 quarters. The position peaked at $11.6M in Q1 2015. 82 funds tracked by Wall St. Rank hold TRIB as of Q4 2015.

RK Capital Management (Colorado) reported no remaining Trinity Biotech position as of Q4 2015 after selling out during the quarter.
RK Capital Management (Colorado) sold 113,094 Trinity Biotech shares in Q4 2015, an estimated $6.47M.
RK Capital Management (Colorado) first reported a position in Trinity Biotech in Q1 2014 and held it in 7 quarters.
RK Capital Management (Colorado)'s Trinity Biotech position peaked at $11.6M in Q1 2015.
82 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2015.

Based on RK Capital Management (Colorado)'s 13F filing for Q4 2015, filed 12 Feb 2016.